Recruiting OBSERVATIONAL NCT06212947

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Sponsor: BioMarin Pharmaceutical

Updated 8 times since 2024 Last updated: Apr 1, 2025 Started: Nov 27, 2023 Primary completion: Dec 31, 2043 Completion: Dec 31, 2043

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hypochondroplasia, this trial is actively recruiting participants. The trial is conducted by BioMarin Pharmaceutical and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Recruiting
May 2025 — Sep 2025 [monthly]

Recruiting
Mar 2025 — May 2025 [monthly]

Recruiting
Oct 2024 — Mar 2025 [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting

▶ Show 3 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2024 — Jul 2024 [monthly]

Recruiting
Feb 2024 — Jun 2024 [monthly]

Recruiting

First recorded

Nov 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioMarin Pharmaceutical

Data source: BioMarin Pharmaceutical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Baltimore, United States , Boston, United States , Buenos Aires, Argentina , Chicago, United States , Cologne, Germany , Columbia, United States , Columbus, United States , Edmonton, Canada , Fort Worth, United States and 32 more locations